Skip to main content
Top
Published in: Journal of Neurology 10/2018

01-10-2018 | Original Communication

Fatigue in patients with myasthenia gravis

Authors: T. M. Alekseeva, Y. V. Gavrilov, O. A. Kreis, P. O. Valko, K. P. Weber, Y. Valko

Published in: Journal of Neurology | Issue 10/2018

Login to get access

Abstract

Background

The subjective feeling of fatigue in myasthenia gravis (MG) is poorly elucidated, in part because it is often confounded with the objective sign of muscle fatigability. Another reason is the paucity of validated fatigue questionnaires in MG.

Methods

We applied the 9-item Fatigue Severity Scale (FSS) and the 40-item Fatigue Impact Scale (FIS) to 73 MG patients and 230 age- and sex-matched control subjects. We ascertained levels of education, marital status, and comorbidities such as depression, sleepiness, sleep times and sleep debt. Disease severity was graded according to the Myasthenia Gravis Foundation of America (MGFA) classification.

Results

All fatigue scores, with the exception of the cognitive FIS subscale, were higher in MG patients than controls. In MG, the prevalence of fatigue (defined by FSS scores ≥ 4.0) was 70%. Multiple regression analyses revealed several independent associates of fatigue, including depression (all fatigue scales), MGFA stage (FSS, physical FIS), female sex (cognitive and psychosocial FIS), and sleep debt (physical FIS).

Conclusion

Fatigue in MG is highly prevalent, mainly physical, and influenced by depressive symptoms, disease severity, female sex and sleep debt. Cognitive fatigue in MG may not be a direct disease manifestation, but secondary to depression. The FSS and FIS represent reliable and validated tools, appropriate to discern meaningful clinical aspects of fatigue in MG. Clinical recognition of the complexity of fatigue may foster individualized treatment approaches for affected MG patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023–1036CrossRef Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023–1036CrossRef
2.
go back to reference Kosachev VD, Alekseeva TM, Khalmurzina AN (2016) Clinical and neurologic characteristic and principles of therapy of late-onset myasthenia gravis. Adv Gerontol 29:658–662PubMed Kosachev VD, Alekseeva TM, Khalmurzina AN (2016) Clinical and neurologic characteristic and principles of therapy of late-onset myasthenia gravis. Adv Gerontol 29:658–662PubMed
3.
go back to reference Valko Y, Rosengren SM, Jung HH et al (2016) Ocular vestibular evoked myogenic potentials as a test for myasthenia gravis. Neurology 86:660–668CrossRef Valko Y, Rosengren SM, Jung HH et al (2016) Ocular vestibular evoked myogenic potentials as a test for myasthenia gravis. Neurology 86:660–668CrossRef
4.
go back to reference Dobkin BH (2008) Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments. Neurorehabil Neural Repair 22:105–110CrossRef Dobkin BH (2008) Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments. Neurorehabil Neural Repair 22:105–110CrossRef
5.
go back to reference Paul RH, Cohen RA, Goldstein JM, Gilchrist JM (2000) Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23:1402–1406CrossRef Paul RH, Cohen RA, Goldstein JM, Gilchrist JM (2000) Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23:1402–1406CrossRef
6.
go back to reference Kluger BM, Krupp LB, Enoka RM (2013) Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80:409–416CrossRef Kluger BM, Krupp LB, Enoka RM (2013) Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80:409–416CrossRef
7.
go back to reference Penner IK, Paul F (2017) Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol 13:662–675CrossRef Penner IK, Paul F (2017) Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol 13:662–675CrossRef
8.
go back to reference Symonette CJ, Watson BV, Koopman WJ, Nicolle MW, Doherty TJ (2010) Muscle strength and fatigue in patients with generalized myasthenia gravis. Muscle Nerve 41:362–369CrossRef Symonette CJ, Watson BV, Koopman WJ, Nicolle MW, Doherty TJ (2010) Muscle strength and fatigue in patients with generalized myasthenia gravis. Muscle Nerve 41:362–369CrossRef
9.
go back to reference Askmark H, Haggård L, Nygren I, Punga AR (2012) Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study. Eur J Neurol 19:1554–1560CrossRef Askmark H, Haggård L, Nygren I, Punga AR (2012) Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study. Eur J Neurol 19:1554–1560CrossRef
10.
go back to reference Kassardjian CD, Murray BJ, Kokokyi S et al (2013) Effects of napping on neuromuscular fatigue in myasthenia gravis. Muscle Nerve 48:816–818CrossRef Kassardjian CD, Murray BJ, Kokokyi S et al (2013) Effects of napping on neuromuscular fatigue in myasthenia gravis. Muscle Nerve 48:816–818CrossRef
11.
go back to reference Cejvanovic S, Vissing J (2014) Muscle strength in myasthenia gravis. Acta Neurol Scand 129:367–373CrossRef Cejvanovic S, Vissing J (2014) Muscle strength in myasthenia gravis. Acta Neurol Scand 129:367–373CrossRef
12.
go back to reference Sabre L, Westerberg E, Liik M, Punga AR (2017) Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries. Brain Behav 7:e00653CrossRef Sabre L, Westerberg E, Liik M, Punga AR (2017) Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries. Brain Behav 7:e00653CrossRef
13.
go back to reference Kittiwatanapaisan W, Gauthier DK, Williams AM, Oh SJ (2003) Fatigue in myasthenia gravis patients. J Neurosci Nurs 35:87–93CrossRef Kittiwatanapaisan W, Gauthier DK, Williams AM, Oh SJ (2003) Fatigue in myasthenia gravis patients. J Neurosci Nurs 35:87–93CrossRef
15.
go back to reference Meriggioli MN, Sanders DB (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 8:427–438CrossRef Meriggioli MN, Sanders DB (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 8:427–438CrossRef
16.
go back to reference Jaretzki A, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16–23CrossRef Jaretzki A, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16–23CrossRef
17.
go back to reference Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF (1994) Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis 18:S79–S83CrossRef Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF (1994) Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis 18:S79–S83CrossRef
18.
go back to reference Hjollund NH, Andersen JH, Bech P (2007) Assessment of fatigue in chronic disease: a bibliographic study of Fatigue Measurement Scales. Health Qual Life Outcomes 5:12CrossRef Hjollund NH, Andersen JH, Bech P (2007) Assessment of fatigue in chronic disease: a bibliographic study of Fatigue Measurement Scales. Health Qual Life Outcomes 5:12CrossRef
19.
go back to reference Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123CrossRef Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123CrossRef
20.
go back to reference Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR (2008) Validation of the Fatigue Severity Scale in a swiss cohort. Sleep 31:1601–1607CrossRef Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR (2008) Validation of the Fatigue Severity Scale in a swiss cohort. Sleep 31:1601–1607CrossRef
21.
go back to reference Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14:540–545CrossRef Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14:540–545CrossRef
22.
go back to reference Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRef Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRef
24.
go back to reference Cronbach LJ (1951) Coefficient alpha and the internal structure of test. Psychometrika 16:297–334CrossRef Cronbach LJ (1951) Coefficient alpha and the internal structure of test. Psychometrika 16:297–334CrossRef
25.
go back to reference Weaver B, Wuensch KL (2013) SPSS and SAS programs for comparing Pearson correlations and OLS regression coefficients. Behav Res Methods 45:880–895CrossRef Weaver B, Wuensch KL (2013) SPSS and SAS programs for comparing Pearson correlations and OLS regression coefficients. Behav Res Methods 45:880–895CrossRef
26.
go back to reference Jordan B, Schweden TLK, Mehl T, Menge U, Zierz S (2017) Cognitive fatigue in patients with myasthenia gravis. Muscle Nerve 56:449–457CrossRef Jordan B, Schweden TLK, Mehl T, Menge U, Zierz S (2017) Cognitive fatigue in patients with myasthenia gravis. Muscle Nerve 56:449–457CrossRef
27.
go back to reference Elsais A, Wyller VB, Loge JH, Kerty E (2013) Fatigue in myasthenia gravis: is it more than muscular weakness? BMC Neurol 13:132CrossRef Elsais A, Wyller VB, Loge JH, Kerty E (2013) Fatigue in myasthenia gravis: is it more than muscular weakness? BMC Neurol 13:132CrossRef
28.
go back to reference Hoffmann S, Ramm J, Grittner U, Kohler S, Siedler J, Meisel A (2016) Fatigue in myasthenia gravis: risk factors and impact on quality of life. Brain Behav 6:e00538CrossRef Hoffmann S, Ramm J, Grittner U, Kohler S, Siedler J, Meisel A (2016) Fatigue in myasthenia gravis: risk factors and impact on quality of life. Brain Behav 6:e00538CrossRef
29.
go back to reference Flachenecker P, Kümpfel T, Kallmann B et al (2002) Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 8:523–526CrossRef Flachenecker P, Kümpfel T, Kallmann B et al (2002) Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 8:523–526CrossRef
30.
go back to reference Baumann CR, Werth E, Stocker R, Ludwig S, Bassetti CL (2007) Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 130:1873–1883CrossRef Baumann CR, Werth E, Stocker R, Ludwig S, Bassetti CL (2007) Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 130:1873–1883CrossRef
31.
go back to reference Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR (2010) Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 17:1428–1436CrossRef Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR (2010) Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 17:1428–1436CrossRef
32.
go back to reference Valko PO, Siddique A, Linsenmeier C, Zaugg K, Held U, Hofer S (2015) Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro Oncol 17:274–281CrossRef Valko PO, Siddique A, Linsenmeier C, Zaugg K, Held U, Hofer S (2015) Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro Oncol 17:274–281CrossRef
33.
go back to reference Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C (2014) The link between multiple sclerosis and depression. Nat Rev Neurol 10:507–517CrossRef Feinstein A, Magalhaes S, Richard JF, Audet B, Moore C (2014) The link between multiple sclerosis and depression. Nat Rev Neurol 10:507–517CrossRef
34.
go back to reference Hackett ML, Köhler S, O’Brien JT, Mead GE (2009) Neuropsychiatric outcomes of stroke. Lancet Neurol 13:525–534CrossRef Hackett ML, Köhler S, O’Brien JT, Mead GE (2009) Neuropsychiatric outcomes of stroke. Lancet Neurol 13:525–534CrossRef
35.
go back to reference Sitek EJ, Bilińska MM, Wieczorek D, Nyka WM (2009) Neuropsychological assessment in myasthenia gravis. Neurol Sci 30:9–14CrossRef Sitek EJ, Bilińska MM, Wieczorek D, Nyka WM (2009) Neuropsychological assessment in myasthenia gravis. Neurol Sci 30:9–14CrossRef
36.
go back to reference Ybarra MI, Kummer A, Frota ER, Oliveira JT, Gomez RS, Teixeira AL (2011) Psychiatric disorders in myasthenia gravis. Arquivos de Neuro-psiquiatria 69:176–179CrossRef Ybarra MI, Kummer A, Frota ER, Oliveira JT, Gomez RS, Teixeira AL (2011) Psychiatric disorders in myasthenia gravis. Arquivos de Neuro-psiquiatria 69:176–179CrossRef
37.
go back to reference Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM (2012) Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 38:J109–J119CrossRef Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM (2012) Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 38:J109–J119CrossRef
39.
go back to reference Odel JG, Winterkorn JM, Behrens MM (1991) The sleep test for myasthenia gravis. A safe alternative to Tensilon. J Clin Neuroophthalmol 11:288–292PubMed Odel JG, Winterkorn JM, Behrens MM (1991) The sleep test for myasthenia gravis. A safe alternative to Tensilon. J Clin Neuroophthalmol 11:288–292PubMed
40.
go back to reference Nicolle MW, Rask S, Koopman WJ, George CF, Adams J, Wiebe S (2006) Sleep apnea in patients with myasthenia gravis. Neurology 67:140–142CrossRef Nicolle MW, Rask S, Koopman WJ, George CF, Adams J, Wiebe S (2006) Sleep apnea in patients with myasthenia gravis. Neurology 67:140–142CrossRef
Metadata
Title
Fatigue in patients with myasthenia gravis
Authors
T. M. Alekseeva
Y. V. Gavrilov
O. A. Kreis
P. O. Valko
K. P. Weber
Y. Valko
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 10/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8995-4

Other articles of this Issue 10/2018

Journal of Neurology 10/2018 Go to the issue